Towards the definition of progressive disease in brain metastasis treated with laser ablation: an evidence-based study.
By: Martin A Merenzon, Adam S Levy, Shovan Bhatia, Cameron Rivera, Alexis A Morell, Alexa Semonche, Lekhaj C Daggubati, Evan Luther, Ricardo J Komotar, Ashish H Shah, Michael E Ivan

Department of Neurological Surgery, University of Miami Miller School of Medicine, Lois Pope Life Center, 1095 NW 14th Terrace 2nd Floor, (D4-6), Miami, FL, 33136, USA. martinmeren@gmail.com.
2023-5-3; doi: 10.1007/s11060-023-04360-0
Abstract

Purpose

The postoperative period after laser interstitial thermal therapy (LITT) is marked by a temporary increase in volume, which can impact the accuracy of radiographic assessment. The current criteria for progressive disease (PD) suggest that a 20% increase in size of brain metastasis (BM) assessed in 6-12 weeks intervals should be considered as local progression (LP). However, there is no agreement on how LP should be defined in this context. In this study, we aimed to statistically analyze which tumor volume variations were associated with LP.

Methods

We analyzed 40 BM that underwent LITT between 2013 and 2022. For this study, LP was defined following radiographic features. A ROC curve was generated to evaluate volume change as a predictor of LP and find the optimal cutoff point. A logistic regression analysis and Kaplan Meier curves were performed to assess the impact of various clinical variables on LP.

Results

Out of 40 lesions, 12 (30%) had LP. An increase in volume of 25.6% from baseline within 120-180 days after LITT presented a 70% sensitivity and 88.9% specificity for predicting LP (AUC: 0.78, p = 0.041). The multivariate analysis showed a 25% increase in volume between 120 and 180 days as a negative predictive factor (p = 0.02). Volumetric changes within 60-90 days after LITT did not predict LP (AUC: 0.57; p = 0.61).

Conclusion

Volume changes within the first 120 days after the procedure are not independent indicators of LP of metastatic brain lesions treated with LITT.



© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

PMID:37306886






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements